Strategies to Accelerate the Development of Gene Therapies
Gene therapy is a growing area of treatment where genes are modified or replaced to treat disease. Rapid growth in gene therapeutics and delivery systems has been facilitated by advanced technologies that enable precise gene editing and characterization of genes and delivery systems. From large-scale screening to focused gene editing, CRISPR is a powerful genome editing technology.
Agilent offers broad gene editing solutions that can be seamlessly integrated to advance the development of your safe and effective gene therapies.
Learning objectives
- Learn more about the gene therapy and gene editing solutions
- Learn more about CRISPR workflow for Cell & Gene Therapy and gain deeper understanding on the CRISPR editing mechanisms
- Learn more about the advanced technological tools ensuring precise gene editing and characterization
Presenter: Parul Angrish, PhD (Director, Biopharma/Pharma Market, Agilent Technologies, Inc.)
Parul Angrish is a Director, Biopharma/Pharma Market at Agilent Technologies. Her focus includes advancing Agilent’s strategic solutions to meet biopharma and pharma customer needs. She has over 15 years of extensive experience in innovating, commercializing and leading cross-functional teams to drive business growth opportunities. Prior to joining Agilent Technologies, she had held several positions at Thermo Fisher Scientific, Life Technologies and DiscoveRx Corporation. She received her Ph.D. in chemistry from the University of Florida. She has co-authored several peer-reviewed articles and is an inventor on several patents.
